BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, November 25, 2024
See today's BioWorld MedTech
Home
» Nanjing Medlander raises $149M in STAR Market listing
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Nanjing Medlander raises $149M in STAR Market listing
Aug. 19, 2022
By
David Ho
No Comments
Nanjing Medlander Medical Technology Co. Ltd. raised ¥1.01 billion (US$148.8 million) with its initial public offering on the Shanghai STAR Market.
BioWorld MedTech
Financings
Public
IPO
Asia-Pacific
